Reckitt Benckiser Group (LON:RKT – Get Free Report) posted its earnings results on Friday. The company reported GBX 147.08 earnings per share for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a net margin of 22.40% and a return on equity of 45.27%.
Reckitt Benckiser Group Trading Up 0.4%
Shares of LON RKT traded up GBX 21 during midday trading on Friday, reaching GBX 5,018. 1,970,654 shares of the stock were exchanged, compared to its average volume of 25,951,900. The company has a debt-to-equity ratio of 108.83, a current ratio of 0.85 and a quick ratio of 0.46. The company has a market capitalization of £31.87 billion, a price-to-earnings ratio of 10.31, a P/E/G ratio of 1.10 and a beta of 0.25. The business has a 50-day simple moving average of GBX 4,706.82 and a two-hundred day simple moving average of GBX 5,378.55. Reckitt Benckiser Group has a 12 month low of GBX 3,866 and a 12 month high of GBX 6,522.92.
Insider Buying and Selling at Reckitt Benckiser Group
In other Reckitt Benckiser Group news, insider Marybeth Hays bought 340 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were acquired at an average cost of GBX 4,585 per share, with a total value of £15,589. Also, insider Shannon Eisenhardt bought 432 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was purchased at an average cost of £432 per share, for a total transaction of £186,624. Over the last 90 days, insiders bought 1,029 shares of company stock valued at $21,416,350. Corporate insiders own 0.44% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on RKT
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
